Profile
Trends
Explore the Research Trends
Research Network
Explore the Expert Network
Publications
-
1.
2013Vonn Walter; Xiaoying Yin; Matthew D. Wilkerson; Christopher R. Cabanski; Ni Zhao; Ying Du; Mei Kim Ang; Michele C. Hayward; Ashley H. Salazar; Katherine A. Hoadley; et al.
PLoS ONE. 2013;8(2). -
2.
2013Juneko E. Grilley-Olson; D. Neil Hayes; Dominic T. Moore; Kevin O. Leslie; Matthew D. Wilkerson; Bahjat F. Qaqish; Michele C. Hayward; Christopher R. Cabanski; Xiaoying Yin; Mark A. Socinski; et al.
Archives of Pathology and Laboratory Medicine. 2013;137(1):32-40. -
3.
2012David Fried; Adam M. Zanation; Benjamin Huang; Neil Hayes; David E. Morris; Julian Rosenman; Mahesh Varia; William Funkhouser; Mark Weissler; Bhishamjit S. Chera
Management of nonesthesioneuroblastoma sinonasal malignancies with neuroendocrine differentiation
Laryngoscope. 2012;122(10):2210-2215.
Similar Experts
- Publications
- 190
- 131
- 40
- 42
- 79
Journals
-
Publications
-
4
-
3
-
3
-
3
-
2
Grants
-
1.
Tom Egan; Keith Burridge; Bill Funkhouser; Scott Randell; Erika Wittchen
Is there NO solution to IRI? Nitric Oxide to Improve and Expand Lung Transplant
1/1/2013 - 12/31/2013
Sponsor: Cystic Fibrosis Foundation
Funding: $ 100,000.00
-
2.
Shelton Earp; Shrikant Bangdiwala; Noel Brewer; William Funkhouser; Marilie Gammon; Paul Godley; Derek Hales; Gary Johnson; Laura Linnan; Felicia Mebane; Wizdom Powell; Allen Rinas; Gwen Sancar; Nicholas Shaheen; Jennifer Smith; Anthony Viera; Dianne Ward; Melissa Spacek
NCCU-LCCC Partnership In Cancer Research (2 of 2)
9/28/2010 - 8/31/2015
Sponsor: NIH National Cancer Institute (NCI)
Funding: $ 942,632.00
-
3.
Alex Duncan; Bill Funkhouser; Mark Heise; Fernando Pardo Manuel de Villena
Regulation of the physiologic and pathologic activation of the NLRP3-inflammasom
5/1/2010 - 4/30/2015
Sponsor: NIH National Institute of Allergy and Infectious Diseases (NIAID)
Funding: $ 60,713.00
Institutional Network
-
Internal OrganizationsShared Pub.
-
19
-
17
-
14
-
13
-
12
-
11
-
External OrganizationsShared Pub.
-
10
-
4
-
3
-
3
-
3
-
2

